Tag Archives: Michael Wiederhorn

Cross Country Healthcare (CCRN) Receives a Rating Update from a Top Analyst

Oppenheimer analyst Michael Wiederhorn maintained a Hold rating on Cross Country Healthcare (CCRN – Research Report) today. The company’s shares closed last Friday at $5.19, close to its 52-week low of $4.50. According to TipRanks.com, Wiederhorn is a top 100

Oppenheimer Maintains a Hold Rating on CVS Health (CVS)

In a report released today, Michael Wiederhorn from Oppenheimer maintained a Hold rating on CVS Health (CVS – Research Report). The company’s shares closed last Tuesday at $61.21. According to TipRanks.com, Wiederhorn is a top 100 analyst with an average

Oppenheimer Gives a Buy Rating to Addus Homecare (ADUS)

In a report released today, Michael Wiederhorn from Oppenheimer assigned a Buy rating to Addus Homecare (ADUS – Research Report), with a price target of $107.00. The company’s shares closed last Monday at $73.92. According to TipRanks.com, Wiederhorn is a

Oppenheimer Maintains Their Buy Rating on Community Health (CYH)

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on Community Health (CYH – Research Report) today and set a price target of $7.00. The company’s shares closed last Friday at $2.80. According to TipRanks.com, Wiederhorn is a top 100 analyst

Cigna (CI) Received its Third Buy in a Row

After Bernstein and Credit Suisse gave Cigna (NYSE: CI) a Buy rating last month, the company received another Buy, this time from Oppenheimer. Analyst Michael Wiederhorn maintained a Buy rating on Cigna today and set a price target of $254.00.

Community Health (CYH) Gets a Buy Rating from Oppenheimer

In a report released yesterday, Michael Wiederhorn from Oppenheimer maintained a Buy rating on Community Health (CYH – Research Report), with a price target of $8.00. The company’s shares closed last Tuesday at $3.68. According to TipRanks.com, Wiederhorn is a